Search - tctmd.com

Displaying 301 - 302 of 302

Sort: Relevancy | Date

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

Decompressing the Left Atrium: V-Wave Interatrial Shunt Therapy for HFrEF

Presentation TCT 2014

Decompressing the Left Atrium: V-Wave Interatrial Shunt Therapy for HFrEF

Presenter: Daniel Burkhoff, Mark Goldberger, Josep Rodés-Cabau

September 16, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.